• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性氧簇(ROS)驱动的丝氨酸473位点的Akt去磷酸化参与4-羟基苯维甲酸(4-HPR)介导的NB4细胞凋亡。

ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.

作者信息

Cao Ji, Xu Danqing, Wang Duoduo, Wu Rui, Zhang Lei, Zhu Hong, He Qiaojun, Yang Bo

机构信息

Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

出版信息

Free Radic Biol Med. 2009 Sep 1;47(5):536-47. doi: 10.1016/j.freeradbiomed.2009.05.024. Epub 2009 May 28.

DOI:10.1016/j.freeradbiomed.2009.05.024
PMID:19482076
Abstract

N-(4-hydroxyphenyl) retinamide (4-HPR), as a synthetic retinoid, has been shown to inhibit carcinogenesis in a variety of cancers. Extensive studies have indicated that ROS are involved in 4-HPR-mediated apoptosis. Herein, we provide further evidence that the Akt signaling pathway is involved in 4-HPR-mediated apoptosis. Of note is the fact that the expression of PI3K (p110) does not change obviously, and neither LY294002 nor insulin could influence the apoptosis induced by 4-HPR. These observations implicate the direct interaction between Akt and ROS. Our data also reveal that 4-HPR-mediated ROS evoke Akt conformational change by forming an intramolecular disulfide bond; N-acetylcysteine and glutathione, as thiol antioxidants, significantly abate the ROS generation in 4-HPR-exposed cells. Further experiments indicate that the conformational change in Akt not only disrupts Akt-Hsp90 binding, but also enhances Akt-PP2A interaction. All these results collectively suggest that 4-HPR-induced apoptosis is associated with a ROS-mediated conformational change in Akt, and this change, as a consequence, mediates dephosphorylation of Akt via regulating Akt-Hsp90 or Akt-PP2A complex formation.

摘要

N-(4-羟基苯基)视黄酸(4-HPR)作为一种合成类视黄醇,已被证明能抑制多种癌症的致癌作用。广泛的研究表明,活性氧(ROS)参与了4-HPR介导的细胞凋亡。在此,我们提供进一步的证据表明,Akt信号通路参与了4-HPR介导的细胞凋亡。值得注意的是,磷脂酰肌醇-3激酶(PI3K,p110)的表达没有明显变化,LY294002和胰岛素均不能影响4-HPR诱导的细胞凋亡。这些观察结果表明Akt与ROS之间存在直接相互作用。我们的数据还显示,4-HPR介导的ROS通过形成分子内二硫键引起Akt构象变化;N-乙酰半胱氨酸和谷胱甘肽作为硫醇抗氧化剂,可显著减少4-HPR处理细胞中ROS的产生。进一步的实验表明,Akt的构象变化不仅破坏了Akt与热休克蛋白90(Hsp90)的结合,还增强了Akt与蛋白磷酸酶2A(PP2A)的相互作用。所有这些结果共同表明,4-HPR诱导的细胞凋亡与ROS介导的Akt构象变化有关,并且这种变化通过调节Akt-Hsp90或Akt-PP2A复合物的形成介导Akt的去磷酸化。

相似文献

1
ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.活性氧簇(ROS)驱动的丝氨酸473位点的Akt去磷酸化参与4-羟基苯维甲酸(4-HPR)介导的NB4细胞凋亡。
Free Radic Biol Med. 2009 Sep 1;47(5):536-47. doi: 10.1016/j.freeradbiomed.2009.05.024. Epub 2009 May 28.
2
[Mechanisms of fenretinide-triggered apoptosis in leukemic cells].[维甲酸诱导白血病细胞凋亡的机制]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):975-8.
3
N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.N-(4-羟基苯基)视黄酰胺(4-HPR)通过产生活性氧诱导白血病细胞死亡。
Int J Hematol. 2003 Oct;78(3):219-25. doi: 10.1007/BF02983798.
4
The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.药理学上的细胞周期蛋白依赖性激酶抑制剂对人白血病细胞的致死作用是通过磷脂酰肌醇3-激酶/蛋白激酶B依赖性过程实现的。
Cancer Res. 2003 Apr 15;63(8):1822-33.
5
Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.维甲酸对神经酰胺生成和代谢的影响——白血病内部及不同白血病之间的差异
Leuk Res. 2015 Oct;39(10):1071-8. doi: 10.1016/j.leukres.2015.06.009. Epub 2015 Jul 2.
6
Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.细胞内谷胱甘肽水平决定细胞对抗肿瘤药物N-(4-羟基苯基)视黄酸诱导凋亡的敏感性。
Anticancer Res. 2005 May-Jun;25(3B):1945-51.
7
N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.N-(4-羟基苯基)视黄酸酰胺通过下调IκBα激酶和核因子-κB调节的基因产物来抑制侵袭、抑制破骨细胞生成并增强细胞凋亡。
Cancer Res. 2005 Oct 15;65(20):9555-65. doi: 10.1158/0008-5472.CAN-05-1585.
8
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.N-(4-羟苯基)视黄酸酰胺与ABT-737在急性淋巴细胞白血病细胞系中的协同作用机制:Mcl-1失活
J Natl Cancer Inst. 2008 Apr 16;100(8):580-95. doi: 10.1093/jnci/djn076. Epub 2008 Apr 8.
9
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.N-(4-羟基苯基)-视黄酰胺在神经母细胞瘤细胞系中增加神经酰胺并诱导混合性凋亡/坏死。
J Natl Cancer Inst. 1999 Jul 7;91(13):1138-46. doi: 10.1093/jnci/91.13.1138.
10
p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.p75 神经生长因子受体与芬维 A 胺诱导神经母细胞瘤的信号转导。
Cancer Chemother Pharmacol. 2014 Feb;73(2):271-9. doi: 10.1007/s00280-013-2355-y. Epub 2013 Nov 20.

引用本文的文献

1
Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway.柴胡皂苷A通过抑制PI3K/Akt信号通路诱导三阴性乳腺癌细胞衰老。
Front Pharmacol. 2025 Apr 25;16:1532579. doi: 10.3389/fphar.2025.1532579. eCollection 2025.
2
Unveiling the therapeutic potential of HZQYF: exploring the inhibitory impact of a clinical herbal formula on gastric cancer through network pharmacology and transcript analysis.揭示化浊祛湿愈溃方的治疗潜力:通过网络药理学和转录组分析探索一种临床中药复方对胃癌的抑制作用
BMC Complement Med Ther. 2025 Apr 17;25(1):142. doi: 10.1186/s12906-025-04871-5.
3
Research progress on pathogenesis of skin pigmentation in chronic liver disease.
慢性肝病皮肤色素沉着发病机制的研究进展
Biomol Biomed. 2025 Apr 26;25(6):1218-1232. doi: 10.17305/bb.2024.11085.
4
Effect of Spicatoside a on Anti-Osteosarcoma MG63 Cells through Reactive Oxygen Species Generation and the Inhibition of the PI3K-AKT-mTOR Pathway.斯皮卡托苷A通过产生活性氧和抑制PI3K-AKT-mTOR通路对骨肉瘤MG63细胞的影响。
Antioxidants (Basel). 2024 Sep 25;13(10):1162. doi: 10.3390/antiox13101162.
5
Pharmacological Akt and JNK Kinase Inhibitors 10-DEBC and SP600125 Potentiate Anti-Glioblastoma Effect of Menadione and Ascorbic Acid Combination in Human U251 Glioblastoma Cells.药理学Akt和JNK激酶抑制剂10-DEBC和SP600125增强甲萘醌和抗坏血酸联合用药对人U251胶质母细胞瘤细胞的抗胶质母细胞瘤作用。
Biomedicines. 2023 Sep 27;11(10):2652. doi: 10.3390/biomedicines11102652.
6
The mechanism of trans-δ-viniferin inhibiting the proliferation of lung cancer cells A549 by targeting the mitochondria.反式-δ-葡萄素通过靶向线粒体抑制肺癌细胞A549增殖的机制。
Front Pharmacol. 2023 May 18;14:1190127. doi: 10.3389/fphar.2023.1190127. eCollection 2023.
7
A Mechanistic Evaluation of Antioxidant Nutraceuticals on Their Potential against Age-Associated Neurodegenerative Diseases.抗氧化营养保健品对其预防年龄相关性神经退行性疾病潜力的机制评估
Antioxidants (Basel). 2020 Oct 20;9(10):1019. doi: 10.3390/antiox9101019.
8
ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin.ROS 介导线粒体 PI3K/AKT 信号通路失活参与硫氧还蛋白还原酶 1 抑制剂白树菌素抑制胃癌的作用。
Cell Death Dis. 2019 Oct 24;10(11):809. doi: 10.1038/s41419-019-2035-x.
9
Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events.利拉鲁肽及其神经保护特性——关注阿尔茨海默病和脑缺血事件中可能的生化机制。
Int J Mol Sci. 2019 Feb 28;20(5):1050. doi: 10.3390/ijms20051050.
10
Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics.肿瘤中的免疫细胞:视黄醇类药物用于化学预防和化疗的新途径。
Br J Pharmacol. 2018 Dec;175(23):4285-4294. doi: 10.1111/bph.14511. Epub 2018 Nov 8.